XRCC4 Antibodies

Santa Cruz Biotechnology provides a broad selection of XRCC4 monoclonal antibodies for research in DNA repair mechanisms. XRCC4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). XRCC4 plays a critical role in the non-homologous end joining (NHEJ) pathway, which is essential for repairing double-strand breaks in DNA. XRCC4 maintains genomic stability and prevents mutations that could lead to cancer. Understanding XRCC4 function is crucial for elucidating the mechanisms of DNA damage response and repair. Researchers can utilize XRCC4 monoclonal antibodies to investigate cellular responses to DNA damage. XRCC4 monoclonal antibodies enable detailed analysis of repair pathway activation and regulation. XRCC4 research with Santa Cruz Biotechnology monoclonal antibodies advances scientific understanding of DNA repair mechanisms and contributes to potential therapeutic developments in cancer research.